Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/140347
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRodriguez-Rodriguez, Patricia-
dc.contributor.authorSandebring-Matton, Anna-
dc.contributor.authorMerino-Serrais, Paula-
dc.contributor.authorParrado-Fernandez, Cristina-
dc.contributor.authorRabano, Alberto-
dc.contributor.authorWinblad, Bengt-
dc.contributor.authorAvila, Jesús-
dc.contributor.authorFerrer, Isidro (Ferrer Abizanda)-
dc.contributor.authorCedazo-Mínguez, Ángel-
dc.date.accessioned2019-09-17T17:27:08Z-
dc.date.available2019-09-17T17:27:08Z-
dc.date.issued2017-12-01-
dc.identifier.issn0006-8950-
dc.identifier.urihttp://hdl.handle.net/2445/140347-
dc.description.abstractInsulin signalling deficiencies and insulin resistance have been directly linked to the progression of neurodegenerative disorders like Alzheimer's disease. However, to date little is known about the underlying molecular mechanisms or insulin state and distribution in the brain under pathological conditions. Here, we report that insulin is accumulated and retained as oligomers in hyperphosphorylated tau-bearing neurons in Alzheimer's disease and in several of the most prevalent human tauopathies. The intraneuronal accumulation of insulin is directly dependent on tau hyperphosphorylation, and follows the tauopathy progression. Furthermore, cells accumulating insulin show signs of insulin resistance and decreased insulin receptor levels. These results suggest that insulin retention in hyperphosphorylated tau-bearing neurons is a causative factor for the insulin resistance observed in tauopathies, and describe a novel neuropathological concept with important therapeutic implications.-
dc.format.extent17 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherOxford University Press-
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1093/brain/awx256-
dc.relation.ispartofBrain, 2017, vol. 40, num. 12, p. 3269-3285-
dc.relation.urihttps://doi.org/10.1093/brain/awx256-
dc.rights(c) Rodriguez-Rodriguez, Patricia et al., 2017-
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)-
dc.subject.classificationMalaltia d'Alzheimer-
dc.subject.classificationMetabolisme-
dc.subject.classificationCervell-
dc.subject.classificationNeurones-
dc.subject.classificationResistència a la insulina-
dc.subject.otherAlzheimer's disease-
dc.subject.otherMetabolism-
dc.subject.otherBrain-
dc.subject.otherNeurons-
dc.subject.otherInsulin resistance-
dc.titleTau hyperphosphorylation induces oligomeric insulin accumulation and insulin resistance in neurons-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/acceptedVersion-
dc.identifier.idgrec689476-
dc.date.updated2019-09-17T17:27:08Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid29053786-
Appears in Collections:Articles publicats en revistes (Patologia i Terapèutica Experimental)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
689476.pdf2.06 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.